There are three stages in a start-up’s life for companies within the life sciences ecosystem. From financial, investor and valuation inflection perspectives, there are really only three stages that matter. CEO360 has developed programs tailored towards the unique needs of each stage. Each program consists of 20-25 Life Sciences CEOs, in the same life stage, meeting monthly for 12 months.
SEED • ANGEL • PRE-SERIES A
Supporting Life Sciences including pharmaceutical, biotechnology (small molecules, biologics, CGT), medical device, med tech, and life sciences tools.
SERIES A / B
Supporting Life Sciences including pharmaceutical, biotechnology (small molecules, biologics, CGT), medical device, med tech, and life sciences tools.
SERIES C+, CROSSOVER, PUBLIC
Supporting Life Sciences including pharmaceutical, biotechnology (small molecules, biologics, CGT), medical device, med tech, and life sciences tools.
A company’s position can help investors, partners, prospective employees and others frame their thinking about current growth and potential for success. Importantly, these stages are defined by qualitative fundamentals and not by some quantitative measure of dollars raised or company age.
CEO360 programs follow a specific curriculum that holds the CEO accountable to achieve the program objectives and milestones. CEO360 utilizes real-world Life Sciences advisors who support the CEO over the program 12-month duration.
© All Rights Reserved • Arrow Up Partners, LLC • 2023